{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:09:02Z","timestamp":1789625342912,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Marie Curie Reintegration Grant (IRG), FP7-PEOPLE-RG-2009","award":["#256402"],"award-info":[{"award-number":["#256402"]}]},{"DOI":"10.13039\/100006812","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX002490"],"award-info":[{"award-number":["BX002490"]}],"id":[{"id":"10.13039\/100006812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (USA)","doi-asserted-by":"crossref","award":["AR055208"],"award-info":[{"award-number":["AR055208"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (USA)","doi-asserted-by":"crossref","award":["AR065407"],"award-info":[{"award-number":["AR065407"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.vph.2015.06.012","type":"journal-article","created":{"date-parts":[[2015,7,3]],"date-time":"2015-07-03T03:29:18Z","timestamp":1435894158000},"page":"17-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Nature and nurture in atherosclerosis: The roles of acylcarnitine and cell membrane-fatty acid intermediates"],"prefix":"10.1016","volume":"78","author":[{"given":"Harry C.","family":"Blair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5577-9766","authenticated-orcid":false,"given":"Jorge","family":"Sepulveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionysios J.","family":"Papachristou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vph.2015.06.012_bb0005","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/humu.1380010602","article-title":"Molecular genetics of the LDL receptor gene in familial hypercholesterolemia","volume":"1","author":"Hobbs","year":"1992","journal-title":"Hum. Mutat."},{"issue":"6646","key":"10.1016\/j.vph.2015.06.012_bb0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(51)91163-4","article-title":"Recent history of coronary disease","volume":"1","author":"Morris","year":"1951","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2015.06.012_bb0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1017\/S0025727300070563","article-title":"Ischaemic heart disease, aortic aneurysms, and atherosclerosis in the City of London, 1868\u20131982","volume":"5","author":"Finlayson","year":"1985","journal-title":"Med. Hist. Suppl."},{"key":"10.1016\/j.vph.2015.06.012_bb0020","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2147\/VHRM.S37119","article-title":"Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions","volume":"9","author":"Kones","year":"2013","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.vph.2015.06.012_bb0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.vph.2015.05.005","article-title":"Methyl-\u03b3-butyrobetaine decreases levels of acylcarnitines and attenuates the development of atherosclerosis","volume":"72","author":"Vilskersts","year":"2015","journal-title":"Vasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.vph.2015.06.012_bb0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/01.ATV.17.1.95","article-title":"Effects of serum lipoproteins and smoking on atherosclerosis in young men and women","volume":"17","author":"McGill","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.vph.2015.06.012_bb0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/aje\/kwt224","article-title":"Validation of a method for reconstructing historical rates of smoking prevalence","volume":"179","author":"Bilal","year":"2014","journal-title":"Am. J. Epidemiol."},{"issue":"8","key":"10.1016\/j.vph.2015.06.012_bb0040","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/01.ATV.0000087143.33998.F2","article-title":"Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease","volume":"23","author":"Thompson","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.vph.2015.06.012_bb0045","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/jcb.24633","article-title":"Elaidate, an 18-carbon trans-monoenoic fatty acid, inhibits \u03b2-oxidation in human peripheral blood macrophages","volume":"115","author":"Zacherl","year":"2014","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.vph.2015.06.012_bb0050","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0002-8223(99)00041-3","article-title":"Estimated intakes of trans fatty and other fatty acids in the US population","volume":"99","author":"Allison","year":"1999","journal-title":"J. Am. Diet. Assoc."},{"key":"10.1016\/j.vph.2015.06.012_bb0055","series-title":"Nobel Lectures in Chemistry, 1901\u20131921","article-title":"The method of direct hydrogenation by catalysis","author":"Sabatier","year":"1912"},{"issue":"6","key":"10.1016\/j.vph.2015.06.012_bb0060","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/07315724.1991.10718180","article-title":"Saturated and hydrogenated fats in food in relation to health","volume":"10","author":"Dupont","year":"1991","journal-title":"J. Am. Coll. Nutr."},{"issue":"6","key":"10.1016\/j.vph.2015.06.012_bb0065","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0022-2275(20)37333-8","article-title":"Human tissue lipids: occurrence of fatty acid isomers from dietary hydrogenated oils","volume":"22","author":"Ohlrogge","year":"1981","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.vph.2015.06.012_bb0070","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.atherosclerosis.2009.03.009","article-title":"The negative effects of hydrogenated trans fats and what to do about them","volume":"205","author":"Kummerow","year":"2009","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.vph.2015.06.012_bb0075","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/ajcn\/64.2.202","article-title":"Dietary fatty acids and progression of coronary artery disease in men","volume":"64","author":"Watts","year":"1996","journal-title":"Am. J. Clin. Nutr."},{"issue":"12","key":"10.1016\/j.vph.2015.06.012_bb0080","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/oxfordjournals.aje.a009074","article-title":"Fatty acids in serum cholesteryl esters as quantitative biomarkers of dietary intake in humans","volume":"145","author":"Zock","year":"1997","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.vph.2015.06.012_bb0085","first-page":"58735","article-title":"Mature human atherosclerotic plaque contains peroxidized phosphatidylcholine as a major lipid peroxide","author":"Piotrowski","year":"1996","journal-title":"Life Sci."},{"key":"10.1016\/j.vph.2015.06.012_bb0090","first-page":"22335","article-title":"Phenotypic modulation of macrophages in response to plaque lipids","author":"Adamson","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.vph.2015.06.012_bb0095","first-page":"95194","article-title":"The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles","author":"Lacolley","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2015.06.012_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1320.001","article-title":"The role of the carnitine system in human metabolism","volume":"1033","author":"Foster","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.vph.2015.06.012_bb0105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1196\/annals.1320.003","article-title":"Kinetics, pharmacokinetics, and regulation of l-carnitine and acetyl-l-carnitine metabolism","volume":"1033","author":"Rebouche","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"8","key":"10.1016\/j.vph.2015.06.012_bb0110","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.numecd.2014.03.007","article-title":"Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: evidence and controversies","volume":"24","author":"Johri","year":"2014","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"3","key":"10.1016\/j.vph.2015.06.012_bb0115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/phrs.2001.0852","article-title":"l-carnitine prevents the progression of atherosclerotic lesions in hypercholesterolaemic rabbits","volume":"44","author":"Sayed-Ahmed","year":"2001","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.vph.2015.06.012_bb0120","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat. Med."},{"issue":"5\u20136","key":"10.1016\/j.vph.2015.06.012_bb0125","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.mam.2004.06.006","article-title":"Carnitine: a nutritional, biosynthetic, and functional perspective","volume":"25","author":"Steiber","year":"2004","journal-title":"Mol. Asp. Med."},{"issue":"17","key":"10.1016\/j.vph.2015.06.012_bb0130","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"50","key":"10.1016\/j.vph.2015.06.012_bb0135","doi-asserted-by":"crossref","first-page":"52160","DOI":"10.1074\/jbc.M409640200","article-title":"Leaky \u03b2-oxidation of a trans-fatty acid: incomplete \u03b2-oxidation of elaidic acid is due to the accumulation of 5-trans-tetradecenoyl-CoA and its hydrolysis and conversion to 5-trans-tetradecenoylcarnitine in the matrix of rat mitochondria","volume":"279","author":"Yu","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.vph.2015.06.012_bb0140","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/jcb.25002","article-title":"Elaidate, an 18-carbon trans-monoenoic fatty acid, but not physiological fatty acids increases intracellular Zn(2+) in human macrophages","volume":"116","author":"Zacherl","year":"2015","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.vph.2015.06.012_bb0145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCRESAHA.114.300738","article-title":"ATP-binding cassette transporters, atherosclerosis, and inflammation","volume":"14","author":"Westerterp","year":"2014","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.vph.2015.06.012_bb0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3945\/an.110.000125","article-title":"Stearoyl CoA desaturase 1: role in cellular inflammation and stress","volume":"2","author":"Liu","year":"2011","journal-title":"Adv. Nutr."},{"issue":"1","key":"10.1016\/j.vph.2015.06.012_bb0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5858\/2008-0795-OAR1.1","article-title":"Variation in human erythrocyte membrane unsaturated fatty acids: correlation with cardiovascular disease","volume":"134","author":"Sepulveda","year":"2010","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"4","key":"10.1016\/j.vph.2015.06.012_bb0160","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11239-012-0687-9","article-title":"Statins, inflammation and deep vein thrombosis: a systematic review","volume":"33","author":"Rodriguez","year":"2012","journal-title":"J. Thromb. Thrombolysis"},{"issue":"8","key":"10.1016\/j.vph.2015.06.012_bb0165","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1074\/jbc.M412531200","article-title":"Statins suppress oxidized low density lipoprotein-induced macrophage proliferation by inactivation of the small G protein-p38 MAPK pathway","volume":"280","author":"Senokuchi","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.vph.2015.06.012_bb0170","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/FJC.0b013e3182927e7c","article-title":"HMG-CoA reductase inhibitors, simvastatin and atorvastatin, downregulate ABCG1-mediated cholesterol efflux in human macrophages","volume":"62","author":"Wang","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"11","key":"10.1016\/j.vph.2015.06.012_bb0175","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1161\/01.ATV.0000143858.15909.29","article-title":"Statin inhibition of Fc receptor-mediated phagocytosis by macrophages is modulated by cell activation and cholesterol","volume":"24","author":"Loike","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"16","key":"10.1016\/j.vph.2015.06.012_bb0180","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.jacc.2013.07.056","article-title":"Targeting the proprotein convertase subtilisin\/kexin type 9 for the treatment of dyslipidemia and atherosclerosis","volume":"62","author":"Urban","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.vph.2015.06.012_bb0185","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.atherosclerosis.2011.11.026","article-title":"Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels","volume":"220","author":"Ferri","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2015.06.012_bb0190","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1038\/nutd.2014.10","article-title":"Effects of LPS and dietary free fatty acids on MCP-1 in 3T3-L1 adipocytes and macrophages in vitro","volume":"4","author":"Cullberg","year":"2014","journal-title":"Nutr. Diabetes"},{"issue":"7","key":"10.1016\/j.vph.2015.06.012_bb0195","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/ATVBAHA.112.250142","article-title":"Stearic acid accumulation in macrophages induces toll-like receptor 4\/2-independent inflammation leading to endoplasmic reticulum stress-mediated apoptosis","volume":"32","author":"Anderson","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.vph.2015.06.012_bb0200","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.4049\/jimmunol.1202208","article-title":"TLR4 activation under lipotoxic conditions leads to synergistic macrophage cell death through a TRIF-dependent pathway","volume":"190","author":"Schilling","year":"2013","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.vph.2015.06.012_bb0205","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1161\/ATVBAHA.112.300188","article-title":"Fatty acids regulate endothelial lipase and inflammatory markers in macrophages and in mouse aorta: a role for PPAR\u03b3","volume":"32","author":"Jung","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.vph.2015.06.012_bb0210","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0022-2275(20)35731-X","article-title":"Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women","volume":"34","author":"Coresh","year":"1993","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.vph.2015.06.012_bb0215","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1194\/jlr.M800410-JLR200","article-title":"Scavenger receptor class B type I-mediated uptake of serum cholesterol is essential for optimal adrenal glucocorticoid production","volume":"50","author":"Hoekstra","year":"2009","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.vph.2015.06.012_bb0220","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.bone.2011.07.002","article-title":"HDL cholesterol and bone mineral density: is there a genetic link?","volume":"50","author":"Ackert-Bicknell","year":"2012","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.vph.2015.06.012_bb0225","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s10875-009-9333-5","article-title":"Autoimmunity, infectious immunity, and atherosclerosis","volume":"29","author":"Matsuura","year":"2009","journal-title":"J. Clin. Immunol."},{"issue":"10","key":"10.1016\/j.vph.2015.06.012_bb0230","doi-asserted-by":"crossref","first-page":"743","DOI":"10.5551\/jat.19281","article-title":"Pathogenic role of modified LDL antibodies and immune complexes in atherosclerosis","volume":"20","author":"Virella","year":"2013","journal-title":"J. Atheroscler. Thromb."},{"issue":"2","key":"10.1016\/j.vph.2015.06.012_bb0235","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ncprheum0092","article-title":"Mechanisms of disease: atherosclerosis in autoimmune diseases","volume":"2","author":"Sherer","year":"2006","journal-title":"Nat. Clin. Pract. Rheumatol."},{"issue":"21","key":"10.1016\/j.vph.2015.06.012_bb0240","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1161\/CIRCULATIONAHA.104.507996","article-title":"Accelerated atherosclerosis in autoimmune rheumatic diseases","volume":"112","author":"Shoenfeld","year":"2005","journal-title":"Circulation"},{"issue":"Suppl. 2","key":"10.1016\/j.vph.2015.06.012_bb0245","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1038\/sj.ejcn.1602973","article-title":"Health effects of trans-fatty acids: experimental and observational evidence","volume":"63","author":"Mozaffarian","year":"2009","journal-title":"Eur. J. Clin. Nutr."},{"issue":"7","key":"10.1016\/j.vph.2015.06.012_bb0250","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJM199008163230703","article-title":"Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects","volume":"323","author":"Mensink","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.vph.2015.06.012_bb0255","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/ajcn\/59.4.861","article-title":"Dietary trans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women","volume":"59","author":"Judd","year":"1994","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.vph.2015.06.012_bb0260","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cca.2013.06.006","article-title":"Foam cells in atherosclerosis","volume":"424","author":"Yu","year":"2013","journal-title":"Clin. Chim. Acta"},{"issue":"6","key":"10.1016\/j.vph.2015.06.012_bb0265","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.autrev.2008.12.018","article-title":"The immunology of atherothrombosis in the antiphospholipid syndrome: antigen presentation and lipid intracellular accumulation","volume":"8","author":"Matsuura","year":"2009","journal-title":"Autoimmun Rev."},{"issue":"3","key":"10.1016\/j.vph.2015.06.012_bb0270","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/jn\/135.3.562","article-title":"Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction","volume":"135","author":"Lopez-Garcia","year":"2005","journal-title":"J. Nutr."},{"issue":"6\u20135","key":"10.1016\/j.vph.2015.06.012_bb0275","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ejcb.2011.09.008","article-title":"Hepatic acute phase proteins\u2014regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-\u03baB-dependent signaling","volume":"91","author":"Bode","year":"2012","journal-title":"Eur. J. Cell Biol."},{"issue":"11","key":"10.1016\/j.vph.2015.06.012_bb0280","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1161\/ATVBAHA.107.161240","article-title":"Chemokines and cardiovascular risk","volume":"28","author":"Aukrust","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"14","key":"10.1016\/j.vph.2015.06.012_bb0285","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1073\/pnas.89.14.6452","article-title":"Long-chain fatty acids activate calcium channels in ventricular myocytes","volume":"89","author":"Huang","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.vph.2015.06.012_bb0290","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1152\/physiolgenomics.00104.2004","article-title":"Gene expression changes associated with fibronectin-induced cardiac myocyte hypertrophy","volume":"18","author":"Chen","year":"2004","journal-title":"Physiol. Genomics"},{"issue":"4852","key":"10.1016\/j.vph.2015.06.012_bb0295","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.vph.2015.06.012_bb0300","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/01.CIR.0000086981.09834.E0","article-title":"Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo","volume":"108","author":"Zhang","year":"2003","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.vph.2015.06.012_bb0305","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1172\/JCI32057","article-title":"Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo","volume":"117","author":"Wang","year":"2007","journal-title":"J. Clin. Invest."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189115001433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189115001433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T21:23:49Z","timestamp":1652736229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189115001433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":61,"alternative-id":["S1537189115001433"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2015.06.012","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nature and nurture in atherosclerosis: The roles of acylcarnitine and cell membrane-fatty acid intermediates","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2015.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}